V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20198354 | 20125772 | 1.44 | 75 | null | null | 2019-08-31 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101703906 |
| 20198358 | 20125773 | 1.7 | 82.8 | Neo-adjuvant (N) | 2016-06-26 | 2016-07-05 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101817985 |
| 20198361 | 20125774 | 1.49 | 41 | Adjuvant (A) | 2017-10-05 | 2017-10-19 | CETUXIMAB | 02 | N | CETUXIMAB | 100041357 |
| 20198362 | 20125775 | 1.81 | 67.2 | Curative (C) | 2018-04-14 | 2018-04-26 | CETUXIMAB | 02 | Y | CETUXIMAB | 101623366 |
| 20198363 | 20125776 | 1.75 | 106 | Curative (C) | 2018-11-30 | 2018-12-06 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101765854 |
| 20198365 | 20125777 | 1.65 | 66.2 | Curative (C) | 2017-10-23 | 2017-11-08 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100930013 |
| 20198367 | 20125778 | 1.61 | 61.45 | null | 2022-03-23 | 2022-05-09 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN | 101405118 |
| 20198369 | 20125779 | 1.72 | 57.3 | Palliative (P) | 2016-02-05 | 2016-09-07 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101467224 |
| 20198372 | 20125780 | 1.65 | 50.4 | Palliative (P) | 2019-12-27 | 2020-03-02 | CETUXIMAB | 02 | null | TRASTUZUMAB | 101185282 |
| 20198379 | 20125781 | 1.8 | 62.9 | null | 2017-12-11 | 2017-12-28 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101133157 |
| 20198381 | 20125782 | 1.56 | 56.7 | null | 2017-04-13 | 2017-05-08 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101542818 |
| 20198382 | 20125783 | 1.72 | 60.8 | Palliative (P) | 2018-02-07 | 2018-02-14 | Trastuzumab Subcutaneous | N | N | TRASTUZUMAB | 100729412 |
| 20198384 | 20125784 | 1.69 | 75.8 | Palliative (P) | 2016-12-25 | 2017-07-31 | CETUXIMAB | 99 | N | CETUXIMAB | 100986303 |
| 20198385 | 20125785 | 1.76 | 67.8 | Palliative (P) | 2017-05-25 | 2017-06-08 | CETUXIMAB | 02 | N | CETUXIMAB | 101653398 |
| 20198386 | 20125786 | 1.82 | 75.3 | Palliative (P) | 2017-05-01 | 2017-05-17 | Cetuximab 7 day (Cycle 1) | 02 | N | TRASTUZUMAB | 100846064 |
| 20198387 | 20125787 | 1.91 | 104.2 | 03 | 2014-03-06 | 2016-10-15 | Trastuzumab 21 day loading dose | N | null | TRASTUZUMAB | 101163080 |
| 20198390 | 20125788 | 1.52 | 70.3 | Palliative (P) | 2014-08-05 | 2017-02-25 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101598680 |
| 20198401 | 20125789 | 1.84 | 86 | null | 2017-05-09 | 2017-12-27 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101412154 |
| 20198412 | 20125790 | 1.75 | 52.1 | Palliative (P) | 2018-11-26 | 2018-12-28 | CETUXIMAB | 02 | N | CETUXIMAB | 100339130 |
| 20198415 | 20125791 | 1.72 | 77.3 | null | 2017-10-27 | 2018-03-21 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 101749489 |
| 20198416 | 20125792 | 1.74 | 73.3 | Palliative (P) | 2017-04-17 | 2017-05-09 | CETUXIMAB | 02 | N | CETUXIMAB | 101343387 |
| 20198417 | 20125793 | 1.68 | 53 | Palliative (P) | 2020-12-20 | 2020-12-22 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101374712 |
| 20198422 | 20125794 | 1.82 | 80.7 | 03 | 2017-05-31 | 2017-11-19 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101613761 |
| 20198430 | 20125795 | 1.77 | 52.4 | Palliative (P) | 2019-01-17 | 2019-01-30 | CETUXIMAB | 02 | N | CETUXIMAB | 100606636 |
| 20198431 | 20125796 | 1.77 | 68 | Palliative (P) | 2017-11-28 | 2017-12-08 | Trastuzumab | N | N | TRASTUZUMAB | 101169050 |
| 20198432 | 20125797 | 1.87 | 70 | Curative (C) | 2018-10-03 | 2018-11-03 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100688112 |
| 20198433 | 20125798 | 1.46 | 75 | null | 2019-07-23 | 2019-07-23 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100781363 |
| 20198435 | 20125799 | 1.88 | 84.8 | Palliative (P) | 2019-09-11 | 2019-09-11 | CETUXIMAB | N | N | CETUXIMAB | 101041762 |
| 20198437 | 20125800 | 1.65 | 104 | Curative (C) | 2018-04-06 | 2018-04-06 | CETUXIMAB | 02 | N | CAPECITABINE + CISPLATIN | 100462396 |
| 20198439 | 20125801 | 1.64 | 74.5 | null | 2016-07-09 | 2016-10-21 | CETUXIMAB | 02 | null | CETUXIMAB | 101344421 |
| 20198441 | 20125802 | 1.59 | 80.75 | null | 2016-05-18 | 2016-05-22 | CETUXIMAB | 99 | null | CETUXIMAB | 101175978 |
| 20198442 | 20125803 | 1.77 | 48.8 | Palliative (P) | 2019-04-18 | 2019-05-04 | Trastuzumab | 02 | N | TRASTUZUMAB | 100413526 |
| 20198447 | 20125804 | 1.83 | 65.5 | Curative (C) | 2019-05-16 | 2020-06-28 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 101569920 |
| 20198448 | 20125805 | 1.83 | 82 | Palliative (P) | 2017-04-23 | 2019-07-29 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100940188 |
| 20198454 | 20125806 | 1.73 | 82.5 | Adjuvant (A) | 2017-06-06 | 2017-06-13 | CETUXIMAB | 99 | N | CETUXIMAB | 101022546 |
| 20198456 | 20125807 | 1.8 | 82.2 | null | 2018-12-10 | 2019-01-03 | CETUXIMAB | 02 | null | CAPECITABINE + CISPLATIN | 100509952 |
| 20198457 | 20125808 | 1.73 | 65.9 | Palliative (P) | 2015-10-28 | 2015-11-11 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100138852 |
| 20198463 | 20125809 | 1.73 | 83.9 | Curative (C) | 2016-02-11 | 2016-03-07 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100216119 |
| 20198466 | 20125810 | 1.63 | 62 | Neo-adjuvant (N) | 2017-05-06 | 2017-07-30 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101013965 |
| 20198469 | 20125811 | 1.75 | 65.9 | Palliative (P) | 2019-10-23 | 2019-11-16 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101383798 |
| 20198471 | 20125812 | 1.84 | 63 | Palliative (P) | 2018-08-04 | 2018-08-04 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101487229 |
| 20198473 | 20125813 | 1.55 | 93.44 | Adjuvant (A) | 2016-10-20 | 2017-03-08 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101537013 |
| 20198475 | 20125814 | 1.62 | 48 | Palliative (P) | 2018-12-15 | 2019-01-12 | Trastuzumab | N | N | TRASTUZUMAB | 101064561 |
| 20198478 | 20125815 | 1.72 | 102.5 | Palliative (P) | 2014-11-05 | 2018-09-16 | Trastuzumab | 02 | null | TRASTUZUMAB | 101356376 |
| 20198482 | 20125816 | 1.83 | 92 | Neo-adjuvant (N) | 2016-07-27 | 2016-08-03 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101197201 |
| 20198484 | 20125817 | 1.51 | 78.2 | Curative (C) | 2021-05-07 | 2021-05-28 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101541226 |
| 20198488 | 20125818 | 1.59 | 65.9 | Adjuvant (A) | null | 2016-06-18 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 99 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100191340 |
| 20198489 | 20125819 | 1.71 | null | Palliative (P) | 2019-11-10 | 2019-11-10 | Irinotecan + Modified De Gramont | N | N | IRINOTECAN + MDG | 101193582 |
| 20198496 | 20125820 | 1.69 | 86.7 | Palliative (P) | null | 2016-08-15 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | IRINOTECAN + MDG | 100421012 |
| 20198499 | 20125821 | 1.55 | 52 | Neo-adjuvant (N) | 2020-01-09 | 2020-02-02 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | null | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101369160 |